Arca Biopharma | ABIO - Equity Capital And Reserves


Arca Biopharma reported $1.11B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Amgen USD 11.69B 2.5B Jun/2026
Arca Biopharma USD 1.11B 627.83M Jun/2026
Biogen USD 18.85B 196.3M Jun/2026
Brainstorm Cell Therapeutics USD -11.6M 588K Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
Capricor Therapeutics USD 246.22M 32.48M Jun/2026
Cipla INR 344.32B 15.13B Mar/2026
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 95.35M 7.38M Mar/2026
CSL USD 18.66B 2.75B Dec/2025
Cytokinetics USD -173.49M 653.08M Jun/2026
Daiichi Sankyo JPY 1.7T 38.53B Jun/2026
Gilead Sciences USD 11.74B 11.77B Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Grifols EUR 6.21B 133.12M Dec/2025
Laboratory Of America USD 8.61B 121.8M Jun/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
Otsuka Holdings JPY 3.24T 131.63B Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026